Loss‐of‐function mutations in PAT2 lead to iminoglycinuria and hyperglycinuria in man [http://www.ncbi.nlm.nih.gov/pubmed/19033659?dopt=AbstractPlus]. This evidence concerns the gene SLC36A2 and Hyperglycinuria.